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ABSTRACT Group 2 capsule polymers represent crucial virulence factors of Gram-
negative pathogenic bacteria. They are synthesized by enzymes called capsule poly-
merases. In this report, we describe a new family of polymerases that combine gly-
cosyltransferase and hexose- and polyol-phosphate transferase activity to generate
complex poly(oligosaccharide phosphate) and poly(glycosylpolyol phosphate) poly-
mers, the latter of which display similarity to wall teichoic acid (WTA), a cell wall
component of Gram-positive bacteria. Using modeling and multiple-sequence align-
ment, we showed homology between the predicted polymerase domains and WTA
type I biosynthesis enzymes, creating a link between Gram-negative and Gram-
positive cell wall biosynthesis processes. The polymerases of the new family are
highly abundant and found in a variety of capsule-expressing pathogens such as
Neisseria meningitidis, Actinobacillus pleuropneumoniae, Haemophilus inﬂuenzae, Biber-
steinia trehalosi, and Escherichia coli with both human and animal hosts. Five repre-
sentative candidates were puriﬁed, their activities were conﬁrmed using nuclear
magnetic resonance (NMR) spectroscopy, and their predicted folds were validated by
site-directed mutagenesis.
IMPORTANCE Bacterial capsules play an important role in the interaction between
a pathogen and the immune system of its host. During the last decade, capsule
polymerases have become attractive tools for the production of capsule polymers
applied as antigens in glycoconjugate vaccine formulations. Conventional production
of glycoconjugate vaccines requires the cultivation of the pathogen and thus the
highest biosafety standards, leading to tremendous costs. With regard to animal
husbandry, where vaccines could avoid the extensive use of antibiotics, conventional
production is not sufﬁciently cost-effective. In contrast, enzymatic synthesis of cap-
sule polymers is pathogen-free and fast, offers high stereo- and regioselectivity, and
works with high efﬁcacy. The new capsule polymerase family described here vastly
increases the toolbox of enzymes available for biotechnology purposes. Representa-
tives are abundantly found in human pathogens but also in animal pathogens, pav-
ing the way for the exploitation of polymerases for the development of a new gen-
eration of vaccines for animal husbandry.
KEYWORDS TagF, capsular polysaccharide, capsule, enzymatic synthesis, nuclear
magnetic resonance, polymerases, polymers, teichoic acids, vaccines, veterinary
vaccine development, Actinobacillus pleuropneumoniae, Haemophilus inﬂuenzae
Bacterial pathogens have developed a variety of strategies to ensure their survival ina host (1). Among these strategies is the expression of a capsule consisting of
extracellular polymers that form an extensive protective layer (1, 2). Capsules are widely
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distributed and found in diverse pathogens such as Escherichia coli, Neisseria meningi-
tidis, Haemophilus inﬂuenzae, Actinobacillus pleuropneumoniae, Staphylococcus aureus,
and Streptococcus pneumoniae (1, 3).
On the basis of the genetic and chemical properties of different E. coli strains,
capsules are divided into four groups (4). Group 2 capsules consist of linear polymers
displaying a high negative-charge density that is introduced by either negatively
charged sugar residues (sialic acid or glucuronic acid) or phosphate groups (1).
Genes required for biosynthesis and export of group 2 capsules are located in the
so-called capsule gene cluster (1, 4–10). It is structured as three regions, of which
regions 1 and 3 are conserved and encode proteins responsible for initiating capsule
biosynthesis and transporting the polymers to the cell surface (see Fig. S1 in the
supplemental material). Region 2 contains the serogroup-speciﬁc capsule polymerases
(referred to here as “polymerases”) that assemble the respective capsule polymers
(Fig. 1a). (Capsule polymers are often referred to as capsule polysaccharides, espe-
cially when they consist exclusively of saccharide units.)
The polymerases described so far can be classiﬁed on the basis of their catalytic
activity as glycosyltransferases (GTs) and hexose-1-phosphate transferases. Polymerases
with GT activity generate glycosidic linkages in polymers consisting exclusively of
saccharide units. On the structural level, the catalytic domains of these enzymes adopt
one of the two most abundant GT folds, i.e., either GT-A or GT-B. The characteristic
elements of both folds are two Rossmann-like domains that are either tightly associ-
ated, forming a central, continuous -sheet (GT-A), or opposed to each other, forming
a deep cleft that contains the catalytic center (GT-B) (11, 12). Polymerases with GT
activity are either single-domain enzymes acting alone to synthesize a homopolymer
(13–16) or, when generating a heteropolymer, acting in concert with another domain
of the same GT fold type, which is either independently expressed (1, 17) or part of the
same polypeptide (18–21).
Polymerases with hexose-1-phosphate transferase activity assemble a polymer in
which monosaccharides are bridged by phosphodiester linkages (22–24). No structural
and little mechanistic data (25–27) are available for these polymerases yet, but they are
believed to be single-domain enzymes displaying sequence motifs that are character-
istic of the members of a protein family called stealth (28).
With enzyme CslB of N. meningitidis serogroup L, we recently described for the ﬁrst
time a polymerase which is able to introduce both linkage types into one polymer,
generating a structure consisting of trisaccharides connected by phosphodiester link-
ages (29). Despite its phosphotransferase activity, CslB shows no similarity to the
hexose-1-phosphate transferases of the members of the stealth protein family. Instead,
it exhibits a so far unique bipartite architecture consisting of an N-terminal GT-A fold
and a C-terminal GT-B-like fold (29).
In the current study, we searched for homologues of CslB and identiﬁed a set of
multidomain polymerases in a variety of animal and human pathogens. One subset
of these polymerases was found to synthesize, like CslB, a poly(oligosaccharide
phosphate) capsule. A second subset, however, was shown to assemble a poly(gly-
cosylpolyol phosphate) polymer that displays considerable similarity to wall teichoic
acid (WTA) type II, a negatively charged polymer and major constituent of the
Gram-positive cell envelope. (Note that the terms polyol and alditol are often
used synonymously in literature describing WTA.) In line with this ﬁnding, bioin-
formatics analysis of all identiﬁed primary protein sequences revealed as a common
denominator a domain that showed sequence similarity to TagF, the wall teichoic
acid synthase from Staphylococcus epidermidis and the best-characterized member
of the so-called TagF-like protein family. Using site-directed mutagenesis, high-
performance liquid chromatography (HPLC), and nuclear magnetic resonance
(NMR) spectroscopy, we conﬁrmed the modeling data and the hypothesized enzy-
matic activity.
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FIG 1 The TagF-like capsule polymerase family. (a) List of TagF-like polymerases characterized in this study and corresponding
bacterial strains and schematic representation of regions A and 2 of their capsule gene cluster. Polymerase-encoding genes are
highlighted in turquoise. (b) Polymer structures generated by TagF-like polymerases consist of linear backbones. Magenta, violet,
and green background colors indicate the domains that are most likely to transfer the respective moiety based on the activity of
the templates used for PHYRE2 modeling. Modiﬁcations (white boxes) are introduced by separate and as-yet-unidentiﬁed
enzymes. (c and d) Schematic domain organization of (c) GT-A/TagF and (d) TagF/GT-B folded polymerases. The length of each
polypeptide in amino acids (aa; indicated in parentheses after each name) as well as the sequence coverage of each modeled
domain is indicated. The majority of polymerases contain a domain rich in tetratricopeptide repeats (TPR) (see Fig. 6). (e) From left
to right: homology model for the GT-A domain (magenta) of Cps1B showing the aspartates of the DxD motif coordinating a Mg2
ion; homology model for the TagF-like domain (green) of Cps7D depicting the two catalytically important histidine residues;
homology model of the GT-B domain (violet) showing the conserved lysine and arginine residues. The importance of the
highlighted active-site amino acids (yellow) is demonstrated in Fig. 7.
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RESULTS
Identiﬁcation of the TagF-like polymerase family. It is known that glycosyltrans-
ferases with similar activities can show low sequence identity (30, 31). Consequently, we
searched for homologues of CslB not only by performing protein BLAST (32) searches
using the CslB amino acid sequence (AEQ62070.1) but also by manually searching the
literature for complex, phosphate-containing group 2 capsules with structures similar
to that of the poly(oligosaccharide phosphate) polymer expressed by N. meningitidis
serogroup L (Fig. 1b; see also Fig. S2 in the supplemental material). The best score (99%
query cover, 58% sequence identity) in the protein BLAST search was obtained for
putative glycosyltransferase Cps12B (AAS77491.1) from A. pleuropneumoniae serotype
12, a pathogen expressing a capsule identical to the polymer generated by CslB (29, 33).
Also among the hits was Ccs2 (AEC50903.1; 97% query cover, 33% sequence identity)
from H. inﬂuenzae serotype c, which expresses a capsule consisting of disaccharide
repeating units connected through phosphodiester linkages (34). Literature searches
revealed that similar dimeric units are expressed by A. pleuropneumoniae serotypes 1
(35) and 4 (36) and by H. inﬂuenzae serotype f (37, 38). Moreover, in a multitude of
bacterial species, one of the hexoses of these dimeric repeating units is replaced by a
glycerol, creating a structure similar to that of WTA type II (39, 40) (Fig. 1b; see also
Fig. S2). Among those species are N. meningitidis serogroup H (41) and serogroup Z (42),
E. coli K2 (43), and A. pleuropneumoniae serotypes 2 (44), 3 (45), 7 (46), 9 (47), and 11
(48) as well as Bibersteinia trehalosi (formerly Mannheimia [Pasteurella] haemolytica [49])
serotypes T3 (50), T4 (51), and T15 (52). Following the hypothesis that all of the linear
polymer backbones mentioned above are generated by homologues of CslB (note that
modiﬁcations of the linear backbone as shown in Fig. 1b [see also Fig. S2] are usually
introduced by separate enzymes [1]), we analyzed the DNA sequence information from
the corresponding strains and identiﬁed putative polymerases in the capsule gene
cluster by their unusual length of more than 2,500 bp per open reading frame (ORF)
(Fig. 1a; see also Fig. S1). Homology modeling, performed for each polypeptide
sequence using the structure prediction software PHYRE2 (53), revealed that all puta-
tive polymerases, like CslB, contained as a common denominator a domain that was
modeled with 100% conﬁdence onto the crystal structure of TagF, the wall teichoic acid
(type I) synthase of the Gram-positive bacterium Staphylococcus epidermidis. The cor-
responding domain is referred to here as TagF-like domain (see Fig. 1c to e; see also
Fig. S3) (54). TagF itself is the most extensively studied member of the TagF-like protein
family, which is characterized by ﬁve active-site primary sequence motifs (54, 55) and
has so far been biochemically investigated using only Gram-positive sources. Despite
their Gram-negative origin and the highly differing percentages of sequence identity
with respect to their TagF-like domains (15% to 93%; see Fig. S4), all polymerases
identiﬁed here contained the ﬁve active-site motifs as shown by multiple-sequence
alignment using the Clustal Omega algorithm (56) (Fig. S5). It thus seems reasonable to
allocate them to the TagF-like protein family and classify them as group 2 TagF-like
polymerases.
In addition to the TagF-like domain, all models were predicted to have either a GT-A
folded domain at the N terminus or a GT-B folded domain C-terminally ﬂanking the
TagF-like domain (Fig. 1c to e; see also Fig. S3). It is of note that the GT-A fold, modeled
onto the -glycosyltransferase domain of capsule polymerase K4CP from E. coli K4 (57),
was present only in strains expressing a capsule with -glycosidic linkage, whereas the
GT-B fold, modeled onto the teichoic acid modifying -glycosyltransferase TarM from
Staphylococcus aureus (58), was found only in strains expressing a polymer with
-glycosidic linkage (Fig. 1b to e; domains and residues are highlighted in magenta
and violet). Despite the considerably differing percentages of sequence identity
(30% to 70% for GT-A and 40% to 90% for GT-B; see Fig. S6), all GT domains were
modeled by PHYRE2 with 100% conﬁdence. The two resulting archetypal polymer-
ase architectures are referred to here as GT-A/TagF-like and TagF-like/GT-B archi-
tectures (see Fig. 1c and d).
Litschko et al. ®
May/June 2018 Volume 9 Issue 3 e00641-18 mbio.asm.org 4
 
m
bio.asm
.org
 o
n
 June 29, 2018 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
Functional testing of recombinant capsule polymerases. To corroborate the
predicted activity of the TagF-like polymerase family, ﬁve representative candidates
were selected for further analyses. Cps12B was chosen due to its high similarity to CslB
(29) (Fig. 1b and c). Cps1B and Ccs2 were additionally selected from the GT-A/TagF-like
subgroup since they generate dimeric instead of trimeric repeating units (Fig. 1b and
c), and Cps3D and Cps7D were selected from the TagF-like/GT-B subgroup as candi-
dates synthesizing WTA-like products (Fig. 1b and d). The ORFs coding for the putative
polymerases were ampliﬁed from bacterial lysates, cloned with different N- and
C-terminal tags (maltose binding protein [MBP] and/or hexahistidine [His6], respec-
tively), and expressed in E. coli. For each polymerase, the constructs yielding the best
expression levels (namely, MBP-Cps12B-His6, MBP-Cps1B-His6, MBP-Cps3D-His6, MBP-
Cps7D-His6, and Ccs2-His6; for concise presentation of the data, all constructs are
displayed here without tags) were puriﬁed by afﬁnity chromatography and subsequent
size exclusion chromatography (SEC) (Fig. S7). Enzymatic activity was tested by incu-
bating each enzyme with its putative donor substrates (nucleotide-activated monosac-
charides or alditols, e.g., UDP-GlcNAc [UDP N-acetylglucosamine] or CDP-glycerol) in
reaction buffer (29) supplemented with magnesium chloride. After 3 h, the reactions
were analyzed using a high-performance liquid chromatography–anion exchange chro-
matography (HPLC-AEC) assay. In all reactions, the consumption of the donor sub-
strates and the simultaneous formation of the nucleotide products (UMP, CMP, UDP)
could be observed in the 280-nm channel (compare control and reaction data in Fig. 2).
Simultaneously, the formation of polymer in Cps12B, Cps1B, and Ccs2 reactions was
detected in the 214-nm channel, whereas polymers generated by Cps3D and Cps7D,
lacking the UV-active N-acetyl group, were visualized by alcian blue/silver-stained
polyacrylamide gel electrophoresis (PAGE) (Fig. 2). It is of note that all reactions took
place in the absence of priming acceptor substrates (e.g., hydrolyzed polymer), dem-
onstrating that all polymerases were able to initiate polymer synthesis de novo. To
evaluate the relevance of Mg2 for the activity of the TagF-like polymerases, the
reactions described above were repeated in the presence of the Mg2-chelating agent
ethylenediaminetetraacetate (EDTA). In agreement with the ﬁndings indicating that
GT-A folded proteins are dependent on divalent cations for the coordination of the
negatively charged donor substrates (11) whereas basic amino acids assume this
function in GT-B folded proteins (12), polymerases with the TagF-like/GT-B architecture
were active even in the presence of EDTA, while the activity of polymerases adopting
the GT-A/TagF-like architecture strictly depended on the presence of Mg2 (Fig. S8).
With the aim of analyzing the structure of the in vitro-synthesized polymers by NMR
spectroscopy, the enzymatic reactions presented in Fig. 2 were upscaled and prepar-
ative AEC was used for polymer puriﬁcation.
NMR analysis conﬁrms the predicted activity of Cps1B, Cps12B, and Ccs2. The
identity between the polymer generated by Cps12B and the previously characterized
polymer generated by CslB (29) could be readily demonstrated by 1H NMR spectros-
copy (Fig. 3a), conﬁrming that Cps12B is the polymerase of A. pleuropneumoniae
serotype 12. 1H, 13C heteronuclear single-quantum correlation (HSQC) experiments
were performed to characterize the products generated by Cps1B and Ccs2 and
demonstrated that the obtained 13C chemical shift values (Fig. 3b and c) (Table 1) were
in perfect agreement with 13C spectra of the native, de-O-acetylated capsule polymer
of A. pleuropneumoniae serotype 1 (35) and H. inﬂuenzae serotype c (34), respectively.
NMR analysis conﬁrms the predicted activity of Cps3D and Cps7D. Similarly, pre-
viously reported 13C and 1H spectra of the capsule polymers harvested from bacterial
cultures of A. pleuropneumoniae serotype 7 (46) and serotype 3 (45) as well as from
N. meningitidis serogroup H (41), which expresses the same polymer backbone as
A. pleuropneumoniae serotype 3 (see Fig. S2), exactly match the 1H-13C correlations
obtained by 1H, 13C HSQC for the polymers generated by Cps7D (Fig. 3d) and Cps3D
(Fig. 3e), proving that both polymerases possessed their predicted activity.
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Nevertheless, an additional set of signals slightly deviating from the published
reference spectra was detected for both C1 and C1= in the Cps7D product (Fig. 3d, red
arrows), and, in addition to the major anomeric signal (76%), two additional minor
anomeric signals (14% and 10%) could be detected in the spectrum of the Cps3D
product (Fig. 3e, black, red, and magenta arrows, respectively).
We hypothesized that the additional signals resulted from the fact that the com-
mercially available CDP-glycerol used in the Cps7D and Cps3D reactions was a racemic
mixture containing both sn-glycerol-1-phosphate (C2= of glycerol has S chirality) and
sn-glycerol-3-phosphate (C2= has R chirality; for nomenclature, see reference 40).
FIG 2 HPLC-AEC and PAGE analyses of different polymerase reactions. (a) CslB. (b) Cps12B. (c) Cps1B. (d) Ccs2. (e) Cps3D. (f) Cps7D. The HPLC-AEC assay allows
the separation and detection of nucleotide activated donor substrates and released nucleotide products in the 280-nm channel (left panels). UV-active polymers
carrying GlcNAc moieties were detected in the 214-nm channel (see panels a to d). UV-inactive polymers were detected using alcian blue/silver-stained PAGE
(e and f).
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FIG 3 NMR characterization of the enzymatically synthesized polymers. (a) 1H NMR comparison of the Cps12B reaction product and the previously characterized
polymer assembled by CslB. (b) 1H, 13C HSQC of the polymer generated by Cps1B. (c) 1H, 13C HSQC of the polymer generated by Ccs2. (d) 1H, 13C HSQC of the
polymer generated by Cps7D. Red arrows indicate correlations that are not in agreement with the previously published spectra for the capsule polymer of
A. pleuropneumoniae serotype 7. (e) 1H, 13C HSQC of the polymer generated by Cps3D. The signal-to-noise ratio was adjusted to show only the resonances
belonging to the dominant spin system containing the anomeric signal with the highest (76%) intensity (black arrow), which is in agreement with the previously
published structure of the A. pleuropneumoniae serotype 3 capsule polymer. The two additional anomeric signals (14% and 10%) resulting from the
incorporation of the nonnatural substrate sn-glycerol-1-phosphate are indicated by red and magenta arrows. Signals labeled with a crosshatch symbol (#) are
due to process-related impurities which were absent in a second batch of Cps3D product (data not shown).
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Clearly, both enantiomers are substrates for the enzymes as shown by the complete
consumption of CDP-glycerol in the HPLC assay (Fig. 2e and f). This is noteworthy, since,
in vivo, both CDP-glycerol and the A. pleuropneumoniae serotype 7 capsule polymer
have been reported to be enantiopure, consisting exclusively of sn-glycerol-3-
phosphate (40, 46) (the stereochemistry of the A. pleuropneumoniae serotype 3 capsule
polymer has not been investigated yet).
Consequently, we performed a comprehensive two-dimensional (2D) NMR analysis
of the glycosidic linkage generated by Cps7D and Cps3D to elucidate if the nonnatural
enantiomer (sn-glycerol-1-phosphate) is incorporated into the polymer and yields the
observed additional signals.
Stereochemistry of the polymer generated by Cps7D. As expected, the 2D total
correlation spectroscopy (TOCSY) spectrum of the Cps7D polymer (Fig. 4a) showed
almost undistinguishable correlations for the two anomeric signals (5.04 ppm/
101.5 ppm and 5.03 ppm/101.1 ppm) observed in the 1H, 13C HSQC (Fig. 3d, see C1 and
red arrow), but their correlations in a 2D nuclear Overhauser effect spectroscopy
(NOESY) spectrum were different (Fig. 4b). This conﬁrmed our hypothesis that the
galactose (Gal) spin systems were similar or identical, whereas the glycerol spin systems
to which they are linked to were different.
In the 2D NOESY analysis (Fig. 4b), the spin system with black labels showed the NOE
values to be 3.65 ppm (strong) and 3.82 ppm (weak), which were assigned to H1a= and
H1b= of sn-glycerol-3-phosphate (Fig. 4c, black structure), matching the values previ-
ously reported for the natural polymer (46). Their corresponding correlations were
isolated in the 13C-HSQC spectrum at 3.83 ppm/71.1 ppm and 3.65 ppm/71.1 ppm
(Fig. 4d). The NOE cross-peak corresponding to 3.65 ppm was much more intense and
could be assigned to the pro-S proton at C1=. The chirality at C2= was found to be R,
based on the scalar couplings observed on the isolated pro-S and pro-R protons
attached to C1= of glycerol. The coupling constant 3JH1=(pro-R)H2= value was found to be
6.0 Hz, a value larger than the value of 3.5 Hz determined for 3JH1=(pro-S)H2= (Fig. 4e), and
ﬁts with the conformation shown in Fig. 4c (black structure), in which H1a= (pro-R) is in
trans to H2=. This agrees with Beynon et al., who determined for the R chirality at C2=
that the 3JH1=(pro-R)H2= value must be equal to or larger than the 3JH1=(pro-S)H2= value,
considering various rotamers (46, 50).
The second anomeric signal of galactose, indicated with red labels, shows NOE
correlations to 3.56 ppm (strong) and 3.87 ppm (weak) (Fig. 4b), which were assigned
to H3a= and H3b= of sn-glycerol-1-phosphate, distinguishing itself from sn-glycerol-3-
phosphate solely by the chirality at C2= (Fig. 4c, red structure). By deﬁnition, the carbon
numbering is inverted. Thus, their correlations in the 13C-HSQC spectrum at 3.56 ppm/
71.4 ppm and 3.88 ppm/71.4 ppm are in the same region as the H1a= and H1b= signals
of the sn-glycerol-3-phosphate (Fig. 4d). The stronger NOE to 3.56 ppm deﬁnes the
pro-S proton at C3=. The fact that the coupling constant 3JH3=(pro-R)H2= 3.9 Hz is smaller
than 3JH3=(pro-S)H2=  7.5 Hz (Fig. 4e) ﬁts with the conformation with S chirality at C2=
TABLE 1 13C chemical shifts of the polymers generated by Cps1B, Ccs2, Cps7D, and
Cps3D, derived from the 1H, 13C HSQC experiment represented in Fig. 3a
Product
13C chemical shifts (ppm)
Glucosamine Galactose
C1 C2 C3 C4 C5 C6 C1= C2= C3= C4= C5= C6=
Cps1B product 101.7 56.3 73.9 74.8 75.9 61.3 96.8 69.1 69.4 70.0 71.0 67.8
Ccs2 product 104.3 57.1 74.1 75.0 76.2 61.6 97.7 69.0 79.9 70.3 73.0 62.2
Galactose Glycerol
C1 C2 C3 C4 C5 C6 C1= C2= C3=
Cps7D product 101.1 70.1 77.7 71.2 73.6 63.9 71.1 72.0 69.2
Cps3D product 100.9 71.2 71.6 77.4 73.5 63.6 64.0 79.9 67.2
aFor the Cps7D and Cps3D products, only the shifts belonging to the naturally identical sn-glycerol-3-
phosphate-containing repeating units are shown.
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FIG 4 Stereochemistry of the polymer generated by Cps7D. The signals indicated in black and red are from spin systems containing sn-glycerol-3-phosphate
and sn-glycerol-1-phosphate, respectively. (a) The 2D TOCSY correlations in the anomeric region demonstrate that the two spin systems are highly similar with
regard to the galactose moiety. (b) The 2D NOESY correlations indicate differences between the two spin systems regarding the linkage to glycerol. (c) Chemical
structures of the Cps7D products containing sn-glycerol-3-phosphate (black structure; C2= has R chirality) and sn-glycerol-1-phosphate (red structure; C2= has
S chirality). The black structure is identical to the backbone of the capsule polymer expressed by A. pleuropneumoniae serotype 7. (d) 1H, 13C HSQC. Correlations
corresponding to the CH and CH2 groups are shown in blue and in green, respectively. (e) The stereochemistry of the glycerol was determined from an 1H NMR
spectrum according to a method described by Beynon et al., who determined for the R chirality at C2= that 3JH1=(pro-R)H2= must be as large as or larger than
3JH1=(pro-S)H2=, whereas for the S chirality at C2=, 3JH3=(pro-R)H2= must be as small as or smaller than 3JH3=(pro-S)H2= (46, 50). (f) Section of the 2D TOCSY data showing
(Continued on next page)
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shown in Fig. 4c (red structure), in which the H1b= (pro-S) is in trans to H2=, again
agreeing with Beynon et al., who determined that 3JH3=(pro-R)H2= must be equal to or
smaller than 3JH3=(pro-S)H2= (46, 50).
The two spin systems of the glycerol are separated in the 2D TOCSY spectrum
(Fig. 4f), which shows that their methylene group (H1= for R chirality and H3= of S
chirality) signals are distinguishable, whereas their resonances with respect to H2= and
the other CH2 group with the phosphate attached are almost identical. The two signals
of phosphate-attached CH2 of glycerol at ~4.04 ppm/69.2 ppm and ~3.98/69.2 ppm in
the 13C-HSQC spectrum contain overlapping signals of H3a= and H3b= for the R chirality
(black label) and H1a= and H1b= for the S chirality (red label). The 2D TOCSY data reveal
that H3a= and H3b= of the R form correspond to chemical shifts of 4.04 and 4.00 ppm,
whereas H1a= and H1b= of the S form correspond to chemical shifts of 4.03 and
3.98 ppm. Both of these methylene groups show correlations to the phosphate in the
1H-31P heteronuclear multiple bond correlation (HMBC) spectrum (Fig. 4g), conﬁrming
the structures shown in Fig. 4c. In summary, the detailed NMR analysis of the Cps7D
product conﬁrmed that the observed second set of signals exclusively resulted from the
incorporation of the nonnatural substrate sn-glycerol-1-phosphate.
Stereochemistry of the polymer generated by Cps3D. For the Cps3D product, our
ﬁrst aim was to clearly conﬁrm the assignment shown for the dominant spin system in
Fig. 3e. The strong anomeric signal at 5.23 ppm belonging to this spin system (black
arrow in Fig. 3e, black structure in Fig. 5a) shows correlations in a 2D TOCSY spectrum
to ﬁve other protons (H2 and H3, H4 and H5, and H6 of galactose), among which one
was signiﬁcantly shifted downﬁeld (Fig. 5b, black labels). Establishing the H1 and H2, H2
and H3, and H3 and H4 correlations in a 2D COSY spectrum (data not shown) showed
that the downﬁeld-shifted resonance can be assigned to H4, which showed a correla-
tion to 31P in a 1H-31P HMBC spectrum, indicating a linkage between phosphate and C4
(Fig. 5c). A strong NOE between the anomeric proton and H2= conﬁrmed the linkage to
C2= of glycerol (Fig. 5d) and thus the identity to the backbone of the capsule polymer
expressed by A. pleuropneumoniae serotype 3 (45) (Fig. 5a, black structure). The chirality
at the glycerol carbon C2=, not determined previously (45), is derived in the following
sections.
At lower contour levels, signals of two other galactose spin systems became visible
(Fig. 5e, marked with red and magenta labels). The TOCSY correlations are practically
identical to those seen with the dominant spin system (Fig. 5b), including the
downﬁeld-shifted H4 resonance, suggesting that they all belong to a galactose with a
phosphate substitution at C4.
The difference between the black and the magenta spin systems becomes apparent
by visualizing the glycosidic linkage as shown in Fig. 5a. Assuming that both repeating
units adopt the most likely populated conformation, in which the exo-anomeric effect
governs the phi-psi angles of the glycosidic linkage, the C3= points toward the reader.
The strong NOE between galactose H1 and H2= observed for both spin systems (Fig. 5a
and d) suggests that H2= is orientated upwards, coming close to galactose C1 and O5.
The chirality at C2= is determined by the phosphate; if the phosphate is attached to C3=
in front, C2= has R chirality (sn-glycerol-3-phosphate, black structure), and if the
phosphate is attached to C1=, C2= has S chirality (sn-glycerol-1-phosphate, magenta
structure). The glycerol CH2 group with the shortest distance to galactose H1 is the one
in front at C3=. Consistent with these considerations, the strongest NOEs with respect
to 4.13 and 4.06 ppm in the black spin system resulted from H3a= and H3b=, which also
showed correlations to 31P (Fig. 5c), conﬁrming that the black spin system had R
chirality at C2= and contained sn-glycerol-3-phosphate. This is further supported by the
effect of the phosphate on the 13C and 1H chemical shifts; C3= was shifted farther
FIG 4 Legend (Continued)
separate spin systems for sn-glycerol-3-phosphate (black) and sn-glycerol-1-phosphate (red). (g) 1H-31P HMBC data conﬁrming the linkages between galactose,
glycerol, and phosphate.
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FIG 5 Stereochemistry of the polymer generated by Cps3D. (a) Structures derived for the spin systems belonging to the major anomeric signal (black) and
the two minor anomeric signals (magenta and red). The strengths of the NOEs between the anomeric proton and various protons of the glycerol are indicated
by blue arrows (see key). (b) Section of the anomeric region of a 2D TOCSY experiment, demonstrating that the galactose moieties in all three spin systems
are linked to a phosphate at C4. (c) Corresponding 1H-31P HMBC. (d) 2D NOESY data indicating that the galactose moieties are linked to C2= of the glycerol
in the black and magenta spin system, whereas the linkage is placed at C1= in the red spin system. (e) 1H, 13C HSQC correlations of all three spin systems.
Signals labeled with a crosshatch symbol (#) are due to process-related impurities which were absent in a second batch of Cps3D product (data not shown).
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downﬁeld than C1= (Fig. 5e), and both H3a= and H3b= appeared to have been shifted
farther downﬁeld than H1= (Fig. 5d). In the case of the magenta spin system, the
strongest NOEs were seen in the upﬁeld resonances of 3.82 and 3.77 ppm, which in turn
did not show correlations to 31P, indicating S chirality. Only a weak NOE was seen for
the H1= signal, which was shifted downﬁeld and showed correlations to 31P and thus
is linked to phosphate, conﬁrming a C2= with S chirality (sn-glycerol-1-phosphate).
While the black-labeled and magenta-labeled spin systems showed a very strong
NOE at 3.98/3.99 ppm (corresponding to H2= of the glycerol and thus indicating a
linkage to C2=), the red spin system showed a strong NOE at 3.58 ppm (Fig. 5a and d),
which originated from a CH2 group (Fig. 5e). Interestingly, the resonances of the red
spin system showed striking similarity to those seen with the sn-glycerol-1-phosphate-
containing repeating units generated by Cps7D (Fig. 5 and 4, red labels). Thus, the
resonance at 3.58 ppm was assigned to the pro-S proton at C3= of sn-glycerol-1-
phosphate. This assignment suggests that the inverted stereochemistry of the nonnat-
ural substrate sn-glycerol-1-phosphate forces Cps3D to misplace the glycosidic linkage
and connect C1 of galactose to C1= of glycerol instead to C2=. However, as shown by
2D TOCSY (Fig. 5b), the phosphodiester bond is still correctly placed at C4 of the
galactose rather than at C3 as reported for the product of Cps7D (compare Fig. 5a and
4a, red structures). In summary, the NMR study data presented above clearly demon-
strate that the observed heterogeneity in the Cps3D product exclusively originated
from incorporation of the nonnatural substrate sn-glycerol-1-phosphate.
Role of the tetratricopeptide domain.Many TagF-like polymerases were predicted
to contain a domain that can be modeled onto templates rich in tetratricopeptide
repeats (TPRs) (Fig. 1c and d; see also Fig. S3). Since TPRs are known for mediating
protein-protein interactions (59), we hypothesized that the predicted TPR domains do
not participate in the catalytic activity of the polymerases. To conﬁrm this hypothesis,
we truncated the TPR domain in Cps1B and Cps7D as representative candidates for the
GT-A/TagF-like and the TagF-like/GT-B architectures, respectively. Unfortunately, the
resulting Cps7D construct showed low expression levels and could not be puriﬁed (data
not shown). Since Cps1B, like many group 2 capsule polymerases (23, 29), was shown
to be expressed as an N-terminal truncation lacking the ﬁrst 31 amino acids (Fig. S7),
the TPR truncation was introduced in Cps1B32–1246, yielding Cps1B32–858. Cps1B32–858
could be expressed and puriﬁed, maintained its activity in the HPLC-AEC assay (data not
shown), and the 1H NMR spectra obtained for the polymer synthesized by Cps1B32–1246
and Cps1B32–858 were identical (Fig. 6a and b). However, it is of note that in analytic size
exclusion chromatography, Cps1B32–1246 eluted with an apparent molecular mass
corresponding to a dimeric to trimeric assembly, whereas Cps1B32–858-His6 appeared to
be monomeric, indicating that the TPR domain mediates oligomerization of Cps1B
(Fig. 6c).
Mutational studies of TagF-like polymerases. The correctness of the PHYRE2
modeling was corroborated by the fact that amino acids known to have catalytic
functions in TagF (H444, 584) (54), K4CP (D519xD521 motif) (57), and TarM (R326, K331)
(58) (all residues involved in coordinating the pyrophosphate of the donor substrate)
could be superimposed with identical residues in the predicted TagF-like, GT-A folded,
and GT-B folded domains, respectively (Fig. 1e), even though the percentage of
sequence identity observed between the predicted domains and their templates was
low (Fig. S4 and S6). Moreover, multiple-sequence alignments performed using Clustal
Omega (56) demonstrated these residues to be part of larger sequence motifs that
appeared to be conserved in both the predicted domains and their corresponding
templates (Fig. S5, S9, and S10). Focusing on Cps1B (expressed as Cps1B32–858-His6) and
Cps7D (expressed as MBP-Cps7D-His6), all conserved positions were mutated to alanine
to give the single-domain mutants Cps1B(D133A/D135A), Cps1B(H587A), and
Cps1B(H717A) (Fig. 7a), as well as Cps7D(H612A), Cps7D(H743A), Cps7D(R1123A), and
Cps7D(K1132A) (Fig. 7b). Mutant constructs were expressed in E. coli and subsequently
puriﬁed at levels comparable to the wild-type levels. As expected, when activity was
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assayed using the HPLC-AEC assay (Fig. 7c to f) and PAGE (Fig. 7g and h), no polymer
synthesis could be observed after 3 h of incubation (Fig. 7g and h) and the level of
UMP/CMP detected in the reactions was comparable to those seen with the negative
controls and could thus be attributed to spontaneous hydrolysis of the donor sub-
strates (Fig. 7e and f, 280-nm channel). Interestingly, considerable levels of UDP, most
likely due to enzyme-facilitated hydrolysis of UDP-galactose (UDP-Gal), could be de-
tected in the presence of TagF-like domain mutants Cps7D(H612A) and Cps7D(H743A)
(Fig. 7f, constructs 2 and 3), indicating that the GT-B folded domain was unaffected by
the mutation in the TagF-like domain and corroborating its GT activity (hexose-1-
phosphate transferase activity would release UMP). Assuming that each single-domain
mutant should still contain one domain that remained functional, we performed
trans-complementation reactions, combining the GT-A domain mutant and the TagF-
like domain mutants of Cps1B as well as the TagF-like domain mutants and the GT-B
domain mutants of Cps7D. Indeed, donor substrate consumption (Fig. 7e and f) and
polymer synthesis (Fig. 7g and h) were restored to wild-type levels in all trans-
complementation reactions, indicating that the two remaining unmodiﬁed domains
were able to catalyze the reaction in trans.
DISCUSSION
This report presents the identiﬁcation of a novel family of bacterial multidomain
enzymes termed TagF-like capsule polymerases that generate complex phosphate-
containing group 2 capsule polymers. PHYRE2 (53) homology modeling, comple-
mented by experimental data, suggests that the TagF-like domain, conserved in all
TagF-like polymerases, catalyzes the transfer of hexose-phosphate and glycerol-
phosphate residues, whereas adjacent GT-A and GT-B folded domains transferred
hexose residues with inverted stereochemistry (-glycosidic linkages) or retained ste-
reochemistry (-glycosidic linkages), respectively. Mutations in the catalytic core, se-
lected based on the template structures of TagF (54), K4CP (GT-A) (57) and TarM (GT-B)
(58), abolished activity, strongly indicating the correctness of the modeling results.
FIG 6 Truncation studies of Cps1B. (a) Chemical structure of the Cps1B product. (b) 1H NMR spectra demonstrating the identity of the polymers generated by
Cps1B32–1246 and Cps1B32–858. (c) Elution proﬁles of an analytic size exclusion chromatography experiment. MW, theoretical molecular mass of the proteins in
a monomeric state; Mobs, observed molecular mass in the experiment.
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FIG 7 Site-directed mutagenesis studies of Cps1B (left panel) and Cps7D (right panel). (a and b) Schematic representation of Cps1B (a) and Cps7D
(b) showing conserved residues in each domain and the single-domain mutants indicated by black bars. (c and d) Cps1B (c) and Cps7D (d) reaction
schemes. (e) HPLC-AEC analyses show that all single-domain mutants (constructs 2 to 4) were unable to produce polymer (214-nm channel). Small
amounts of UMP/CMP detected in the reactions of Cps1B (e) and Cps7D (f) mutants were found in the controls (standards) as well, indicating that
they resulted from spontaneous, enzyme-independent hydrolysis (280-nm channel). However, combining two single-domain mutants in trans
restores donor substrate uptake and polymer synthesis, as documented by HPLC-AEC (214-nm channel) (e and f) and alcian blue/silver-stained
PAGE (g and h).
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Importantly, trans-complementation restored activity to wild-type levels, corroborating
that each domain is independent from the other with regard to activity and folding.
Using size exclusion chromatography and 1H NMR, we showed that the TPR (tet-
ratricopeptide repeat) domain, predicted at the N terminus or C terminus of the
majority of TagF-like polymerases, mediates oligomerization in Cps1B but is not re-
quired for enzymatic activity. Unfortunately, attempts to truncate the N-terminal TPR
domain in Cps7D resulted in abolishment of expression, suggesting that the TPR
domain may play a more important role with regard to protein stability and/or folding
in polymerases with TagF-like/GT-B architecture. Given the considerable size
(~400 amino acids) of the predicted TPR domains, it is likely that they adopt other
functions in the in vivo context, such as mediating interactions with the ABC transporter
of the capsule biosynthesis complex, with polymer-modifying enzymes, or with sugar/
glycerol-activating enzymes (1).
Bacteria expressing TagF-like polymerases were largely identiﬁed through analysis
of published capsule structures (only Cps12B, Cps4B, and Ccs2 could be identiﬁed by
BLAST searches performed using the CslB sequence as the query). Those bacterial
species are as diverse as the meningitis-causing agent N. meningitidis and uropatho-
genic E. coli K2 (both human pathogens) and the animal respiratory pathogens A. pleu-
ropneumoniae and B. trehalosi. Consequently, the polymer structures generated by
TagF-like polymerases as well as the sequence identity between the enzymes can vary
considerably. The neisserial polymerases CslB and Cshc, which generate a trimeric
poly(oligosaccharide phosphate) and a dimeric poly(glycosylpolyol phosphate) repeat-
ing unit (29, 41), respectively, share only 14% sequence identity, whereas enzymes
generating identical structures can share up to 70% sequence identity. Consistent with
the fact that the TagF-like domain is most ambiguous (it is able to transfer both
glycerol-phosphate and hexose-phosphate residues), the percentages of sequence
identity between TagF-like domains from different strains represent a large range of
diversity (from 15% to 93%), whereas the GT-A and GT-B folded domains share 30% to
70% and 40 to 90% identity, respectively. To retrospectively assess the distribution of
TagF-like polymerases, BLAST searches were performed using the amino acid se-
quences of newly identiﬁed Cps1B and Cps7D, yielding homologues with sequence
identities ranging from 35% to 65% in a variety of pathogens such as Actinobacillus suis,
Campylobacter jejuni, Campylobacter coli, Mannheimia varigena, Neisseria mucosa, and
Yersinia enterocolitica. This ﬁnding suggests that TagF-like polymerases also play a role
in a multitude of bacterial species whose capsule structures have not been investigated
yet.
Capsule polymers are utilized to produce efﬁcient glycoconjugate vaccines, in which
polymer fragments are covalently coupled to carrier proteins to elicit T-cell responses
and immunologic memory (60). Immunizations with glycoconjugates containing cap-
sule polymers from, e.g., H. inﬂuenzae, S. pneumoniae, and N. meningitidis, have been
proven highly successful in preventing infectious diseases in humans (61), and exper-
imental glycoconjugate vaccines against animal pathogens, e.g., A. pleuropneumoniae
serotype 1, have been documented to produce strong immune responses (62, 63).
Unfortunately, the biohazards and costs associated with glycoconjugate production are
key barriers for broad market launch (64). Current protocols require isolation of capsule
polymers from large-scale fermentation of pathogenic bacteria. This step essentially
depends on the high-tech infrastructure of modern production plants, which require
the highest biosafety standards (61), making glycoconjugate vaccines expensive; not
sufﬁciently accessible to low-income countries; and, with regard to animal husbandry,
where they could reduce/avoid the exuberant use of antibiotics, not sufﬁciently cost-
effective (65, 66). We recently showed that enzymatic synthesis of the capsule polymer
from N. meningitidis serogroup X provides a simple, biohazard-free, and thus potentially
more cost-effective means for the production of a functional glycoconjugate vaccine
(25, 27, 67). The identiﬁcation of the TagF-like polymerase family vastly increases the
number of enzymes and thus the number of capsule polymers available for the
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development of glycoconjugate vaccines against other human and even animal patho-
gens.
The poly(glycosylpolyol phosphate) structures generated by the TagF-like/GT-B
folded polymerases have in the past been described as teichoic acid-like polymers due
to their similarity to WTA type II (48, 50), a common polymer of the cell envelope of
Gram-positive bacteria. Unfortunately, little is known about WTA type II biosynthesis
and further studies are needed to investigate if homologues of TagF-like polymerases
play a role (39, 40). Nonetheless, TagF (54) and TarM (58), the template structures for
modeling the TagF-like domain and the GT-B domain, polymerize and modify wall
teichoic acid type I, respectively. Despite the fact that TarM and TagF are expressed in
Gram-positive bacteria and act as separate polypeptides, they share conserved amino
acids and, in case of TagF, even all active-site motifs (54) with the domains of the
TagF-like polymerases. It is thus tempting to speculate that they were acquired by
Gram-negative group 2 capsule-expressing bacteria through horizontal gene transfer or
vice versa. Further research is needed to elucidate the evolutionary relationship be-
tween WTA type I and group 2 capsule biosynthesis.
The NMR characterization of the Cps7D and Cps3D products clearly demonstrated
that both enzymes consumed sn-glycerol-3-phosphate and sn-glycerol-1-phosphate
from the racemic CDP-glycerol mixture, whereas A. pleuropneumoniae serotype 3 and 7
capsules exclusively contain sn-glycerol-3-phosphate (45, 46). sn-Glycerol-1-phosphate
is commonly found in lipoteichoic acid and is supplied from the donor substrate
phosphatidylglycerol on the outer side of the Gram-positive cell membrane, whereas
the sn-glycerol-3-phosphate found in WTA is usually provided by CDP-glycerol in the
cytosol (40). In agreement with that, group 2 capsule biosynthesis takes place on the
cytoplasmic side of the inner membrane and a glycerol-3-phosphate cytidylyltrans-
ferase has been predicted in region 2 of the A. pleuropneumoniae serotype 3 and 7
capsule gene cluster (10). It is tempting to speculate that the lack of selective pressure
for sn-glycerol-3-phosphate resulting from the absence of sn-glycerol-1-phosphate in
the cytosol is the reason for the observed substrate ambiguity of Cps7D and Cps3D.
In contrast to all other polymerases analyzed in this study, the candidates from
B. trehalosi (B. trehalosi 188 [Bt188], Bt189, Bt192, and BtY31 [68, 69]) (see Fig. S2 and
Fig. S3 in the supplemental material) were identiﬁed in genomes of nonserotyped
strains. The capsules of three of the four known B. trehalosi serotypes have been
analyzed by NMR in the past, and all of those studies reported a poly(glycoslypolyol
phosphate) structure (50–52). In agreement with these ﬁndings, the polymerases
encoded in the Bt188, Bt189, and Bt192 genomes adopt the TagF-like/GT-B architec-
ture. Interestingly, homology modeling for the polymerase encoded in the BtY31
genome predicts a GT-A/TagF-like fold, suggesting that BtY31 expresses a poly(oligo-
saccharide phosphate) capsule. Although a structural analysis of the BtY31 capsule
polymer will be required for conﬁrmation, this ﬁnding already highlights that the
knowledge presented here about the TagF-like polymerase family can be exploited to
predict the composition of unknown capsule structures, providing a starting point for
structural analyses.
In summary, the identiﬁcation of the TagF-like capsule polymerase family (i) reveals
a new class of polymerases known to be involved in group 2 capsule biosynthesis, (ii)
represents a new source for synthetic biomaterials, (iii) allows conclusions to be drawn
with respect to the relationship between the protein repertoire and capsule structure,
and (iv) potentially provides a link between cell wall biosynthesis in Gram-positive and
that in Gram-negative bacteria.
MATERIALS AND METHODS
Bioinformatics. Homologues of CslB were identiﬁed by protein BLAST searches using the CslB amino
acid sequence as the query and the BLASTP algorithm (32), homology modeling was performed using the
intensive mode of the structure prediction tool PHYRE2 (53), and sequence alignments were performed
using Clustal Omega (56).
General cloning. The generation of plasmid pΔN37-cslB-His6 (tac) encoding CslB38–874-His6 was
described previously (29). cps1B (GenBank accession number KY798410), cps3D (GenBank accession
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number KY807157), cps7D (GenBank accession number ACE62291.1), cps12B (GenBank accession number
AY496881.1), and ccs2 (GenBank accession number AEC50903.1) were ampliﬁed by PCR from heat-
inactivated bacterial lysates using the primers given in Tables 3 and 4. The resulting PCR products
ampliﬁed from cps1B, cps3D, cps7D, and cps12B were cloned via the indicated restriction sites (Tables 3
and 4) into plasmid pMBP-csxA-His6 (tac) (22), replacing the csxA sequence and resulting in pMBP-cps1B-
His6, pMBP-cps3D-His6, pMBP-cps7D-His6, and pMBP-cps12B-His6, respectively. ccs2 was cloned into
pΔN37-cslB-His6 (tac) (29). Single-amino-acid mutations and truncations were introduced using a Q5
site-directed mutagenesis kit (New England Biolabs) according to the manufacturer’s guidelines. Plasmid
pcps1B32–858-His6 (tac) was cloned in two steps. First, plasmid pcps1B32–1246-His6 (tac) was generated with
primers CL102/CL104 and pMBP-cps1B-His6 as the template. Subsequently, plasmid pcps1B32–858-His6
(tac) was generated with primers CL128/CL129 and pcps1B32–858-His6 as the template. Single amino acid
mutations were generated using primers shown in Table 4 and pcps1B32–858-His6 (tac) or pMBP-cps7D-
His6 as the template.
Expression and puriﬁcation of recombinant proteins. Expression and puriﬁcation of recombinant
constructs were performed as previously described (29). Brieﬂy, E. coliM15[pREP4] cells were transformed
with the plasmids shown in Table 3 and protein expression was induced with 1 mM IPTG (isopropyl--
D-thiogalactopyranoside) when 500 ml of expression culture (Power Broth medium) reached an optical
density at 600 nm (OD600) of 0.6 to 1.0. Expression was performed at 15°C and 200 rpm for 21 h. After
the cells were harvested by centrifugation, the cell pellet was resuspended in lysis buffer (50 mM Tris
[pH 8.0], 500 mM NaCl, 2 mM dithiothreitol [DTT], 0.2 mg/ml DNase [Roche], 0.1 mg/ml RNaseA [Roche],
0.1 mg/ml lysozyme [Serva], and EDTA-free protease inhibitor [Complete EDTA-free; Roche]) and the cell
suspension was subjected to soniﬁcation (Branson Digital Soniﬁer) (50% amplitude; soniﬁcation was
performed 8 times for 30 s each time with cooling on ice between the soniﬁcation stops). Recombinant
His6-tagged proteins were enriched by immobilized metal ion afﬁnity chromatography and eluted using
an imidazole gradient (25 to 500 mM imidazole over 20 min). Protein-containing fractions were pooled
and applied to a size exclusion chromatography column (Superdex 200 10/300 GL [GE Healthcare] or
HiPrep 26/10 Desalting [GE Healthcare]) for further puriﬁcation and/or buffer exchange, after which
aliquots were snap-frozen in liquid nitrogen and stored at 80°C. Analytic size exclusion chromatogra-
phy was performed using a Superdex 200 10/300 Gl column (GE Healthcare) and a gel ﬁltration marker
kit for protein molecular weights 12,000 to 200,000 (Sigma) according to the manufacturer’s guidelines.
Enzymatic reactions and analysis via HPLC and polyacrylamide gel electrophoresis (PAGE).
Enzymatic reactions were carried out with 0.1 to 0.3 nmol of puriﬁed protein in a total volume of 75 l
of assay buffer (20 mM Tris [pH 8.0], 1 mM DTT, 10 mM MgCl2, 6 to 10 mM donor sugar). UDP-GlcNAc
(Carbosynth), UDP-Gal (Carbosynth), and CDP-glycerol (racemic; from Sigma-Aldrich) were used as donor
substrates as indicated in Fig. 2. Reaction mixtures containing wild-type proteins were incubated for 24 h
at 37°C, while mutant constructs were incubated for 3 h at 37°C to minimize spontaneous hydrolysis of
donor substrates. HPLC-based anion exchange chromatography (HPLC-AEC) was performed on a Prom-
inence UFLC-XR system (Shimadzu) equipped with a CarboPac PA-100 column (Dionex) (2 by 250 mm).
Samples were separated as described in reference 29, with the adjustment that 20 mM Tris (pH 8.0) and
20 mM Tris (pH 8.0) plus 1 M NaCl were used as mobile phases M1 and M2, respectively. Six microliters
of the samples was loaded for the detection of nucleotides at 280 nm and 50 l for the detection of
capsule polymer at 214 nm. Nucleotides were separated using a linear elution gradient of 0% to 30% M2
over 11 min. Polymers were separated using an elution gradient consisting of a 2 curved gradient of
0% to 30% M2 over 4 min followed by a linear gradient of 30% to 84% M2 over 33 min. Chromatography
TABLE 2 Strains, polymerases, and corresponding accession numbers used in this study
Strain Polymerase
GenBank
accession no.
Actinobacillus pleuropneumoniae 4074 Cps1B KY798410
Actinobacillus pleuropneumoniae S1421 Cps3D KY807157
Actinobacillus pleuropneumoniae AP76 Cps7D ACE62291.1
Actinobacillus pleuropneumoniae 8329 Cps12B AY496881.1
Haemophilus inﬂuenzae ATCC 9007 Ccs2 AEC50903.1
TABLE 3 Plasmids used in this studya
Plasmid
Recombinant
construct
Molecular
mass (kDa) Primer
Restriction
sites
pMBP-cps1B-His MBP-Cps1B-His 190 CL57/CL59 BamHI/AvrII
pMBP-cps3D-His MBP-Cps3D-His 177 CL147/CL148 BamHI/XhoI
pMBP-cps7D-His MBP-Cps7D-His 192 CL74/CL94 BamHI/AvrII
pMBP-cps12B-His MBP-Cps12B-His 146 CL33/CL56 BamHI/XhoI
pccs2-His Ccs2-His 144 CL40/CL39 NdeI/XhoI
pCps1B32–1246-His Cps1B32–1246-His 144 CL102/CL104
pCps1B32–858-His pCps1B32–858-His 99 CL128/CL129
aMBP, maltose binding protein.
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was conducted at 0.6 ml/min with a column temperature of 50°C. Four-microliter volumes of Cps3D and
Cps7D reaction samples mixed with 4 l of a 2 M sucrose solution were used for separation on
high-percentage (15%) PAGE and visualized by a combined alcian blue/silver staining procedure as
described in reference 70.
SDS polyacrylamide gel electrophoresis (SDS-PAGE) was performed as described in reference 29.
Upscaling of in vitro polymer synthesis and subsequent puriﬁcation. For in vitro synthesis of 5
to 12 mg of polymer, protein (1 to 25 nmol) was incubated overnight at 37°C in reaction buffer (20 mM
Tris [pH 8.0], 10 mM MgCl2, 1 mM DTT) with a 6 to 10 mM concentration of the activated substrates in
a total volume of 5 to 10 ml. In vitro-synthesized polymer was puriﬁed by anion exchange chromatog-
raphy (AEC) using a MonoQ HR10/100 Gl column (GE Healthcare) and a linear NaCl gradient (over 41 min)
starting at 0 to 1 M NaCl at a ﬂow rate of 1 ml/min. Polymer-containing fractions were pooled, dialyzed
against water (ZelluTrans; Roth) (1,000 molecular weight cutoff [MWCO]), and freeze-dried for further
analysis.
NMR analysis. The NMR spectra shown in Fig. 3a to c and described in Table 1 were determined
using a BrukerAvance III 400 MHz spectrometer equipped with a 5-mm broadband probe (Bruker). 1H
NMR spectra were collected at 298 K with 32,000 data points over a 10-ppm spectral width, accumulating
TABLE 4 Primers used in this study
Primer designation
or categorya Primer sequenceb
CL57 5=-CCATAGGGATCCAATAAAGTAAAACGTAAATTTAG-3=
CL59 5=-CTTTTACCTAGGAACGCCCAACTTAATTAACATTAGTGGTGGTGGTGGTGGTGCTCGAGG
ATGAATTTTTCAAAAAAGATAG-3=
CL147 5=-CCATAGGGATCCTTAATAAACAACGAGAATG-3=
CL148 5=-GGTGCTCGAGTTTAGTATTTTCGTTAAATTC-3=
CL74 5=-CCATAGGGATCCAAGAAAAAATTTTATAAAGC-3=
CL94 5=-CTTTTACCTAGGAACGCCCAACTTAATTAACATTAGTGGTGGTGGTGGTGGTGCTCGAGA
ATAACATTATAAAATCTATTAATTG-3=
CL33 5=-CCATAGGGATCCAATAAAATTAGTA-3=
CL56 5=-GGTGCTCGAGGTTTATATTTCTTTTTGG-3=
CL40 5=-GCATCTCATATGAGCAAAATCAATAGAAAACTTAAGAAAC-3=
CL39 5=-GGTGCTCGAGTGAAAGTAAATCGGCTAATTTTAATTG-3=
Primers used for generating truncated
Cps1B constructs
CL102 5=-AAACATTTACCTGTTAAATATGAAG-3=
CL104 5=-CATGGACTATGGTCCTTG-3=
CL128 5=-ATCCGGCATATCTAAGTTAATAATAG-3=
CL129 5=-CTCGAGCACCACC-3=
Primer pairs used for generating the
underlined mutations in cps1B
D133A/D135A
CL162 5=-TTACCTTTATTGCGCCAGCGGATTTTCTTAG-3=
CL163 5=-CCCATTCTGTTTGTACGTATTTTAGTCC-3=
H743A
CL137 5=-TAAAGATGATTTATCTCAATGGTTC-3=
CL136 5=-GTTATACCCGCCTGTAAA-3=
H717A
CL164 5=-CCATATTTAAATGAGTTTAACATCCCC-3=
CL165 5=-TTCAATATTAGGCGCTGGTGCAAAAATAAC-3=
Primer pairs used for generating the
underlined mutations in cps7D
H612A
CL177 5=-TTAAAACATTAGGAAGAGATATGGAG-3=
CL176 5=-ATGGAGTTCCCGCCCATGTAC-3=
H743A
CL179 5=-AAGCATTATCCAAAATTAATCTAG-3=
CL178 5=-CCTGAAGTAATGACGCCCCTCTAA-3=
R1123A
CL181 5=-GAGAAGGACCACGCTAAGT-3=
CL180 5=-TATTGATAGCGCACCTATTGTT-3=
K1132A
CL160 5=-GCTAAGTTAATTAATAGTTTTGC-3=
CL159 5=-GTGGTCCGCCTCTATT-3=
aPrimers not otherwise deﬁned were used for generating the constructs shown in Table 3.
bRestriction sites are underlined.
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an appropriate number of scans. The spectra were generally weighted with 0.2-Hz line broadening and
were subjected to Fourier transformation. The transmitter was set at the water frequency which was used
as the reference signal (4.79 ppm). All the 1H spectra were obtained in a quantitative manner using the
total recycle time to ensure a full recovery of each signal (5  longitudinal relaxation time T1). 13C NMR
spectra were recorded at 100.6 MHz and 298 K, with 32,000 data points over a 200-ppm spectral width,
accumulating an appropriate number of scans. The spectra were generally weighted with 1.0-Hz line
broadening and were subjected to Fourier transformation. The transmitter was set at the acetone
frequency, as an external calibration, which was used as the reference signal (30.89 ppm).
Data from two-dimensional 1H, 13C HSQC experiments were acquired with a standard pulse program.
Totals of 4,096 and 512 data points were collected in the F2 and F1 dimensions, respectively. An
appropriate number of scans were accumulated prior to Fourier transformation to yield digital resolu-
tions of 0.2 Hz and 1.0 Hz per point in F2 and F1, respectively.
NMR measurements shown in Fig. 3d and e, 4, and 5 were recorded on a Bruker Avance III HD 600
MHz spectrometer with a QXI room-temperature probe for 1H/13C/15N/31P (Bruker Biospin, Germany).
Polymers were dissolved in 500 l and measured in standard 5-mm TA tubes (Armar, Germany) at 298 K.
The temperature was calibrated with methanol-d4 (Armar, Germany) (99.8% D), and spectra were
calibrated in 1H using the Bruker standard sample of 2 mM sucrose–0.5 mM DSS (4,4-dimethyl-4-
silapentane-1-sulfonic acid). 13C frequencies were calibrated indirectly using the recommended scaling
factor  of 0.25144953. Indirect referencing of 31P chemical shifts was performed using the chemical
shift ratio 0.404808636 as advised by the Biological Magnetic Resonance Data Bank. 1H NMR spectra were
recorded with 64,000 data points and a spectral width of 20 ppm, typically using 64 transients. 31P NMR
spectra were recorded with 16,000 data points and a spectral width of 50 ppm, typically using 64
transients. 2D 1H-13C HSQC spectra were measured using the Bruker pulse sequence hsqcedetgpsisp2.2
with 2,048- and 16-ppm spectral widths for 1H and 230 data points and a 60-ppm spectral width using
32 scans and a recycle delay of 1.5 s, resulting in a measurement time of 3.5 h. 2D 1H-1H TOCSY spectra
were collected with 2,-048- and 13.9-ppm spectral widths for 1H and 512 data points and a 13.9-ppm
spectral width using 4 scans, a mixing time of 80 ms, and a recycle delay of 2 s, resulting in a
measurement time of 1.5 h. 2D 1H-1H COSY spectra were collected using cosygpppqf with 2,048- and
10-ppm spectral widths for 1H and 128 data points and a 10-ppm spectral width using 32 scans and a
recycle delay of 2 s, resulting in a measurement time of 2 h 40 min. 2D 1H-31P HMBC spectra were
recorded using the pulse sequence hmbclpndqf with 4,096- and 10-ppm spectral widths for 1H and 64
data points and a 30.5-ppm spectral width using 32 scans and a recycle delay of 1.5 s, resulting in a
measurement time of 1 h 12 min. 2D 1H-1H NOESY spectra were collected with 2,048- and 10-ppm
spectral widths for 1H and 700 data points and a 10-ppm spectral width using 32 scans, a mixing time
of 120 ms, and a recycle delay of 1 s, resulting in a measurement time of 8 h 20 min. 2D 1H-13C HMBC
spectra were recorded using the pulse sequence hmbclpndqf with 4,096- and 20-ppm spectral widths for
1H and 512 data points and a 222-ppm spectral width using 64 scans, optimized for a JCH long-range
coupling of 8 Hz and a recycle delay of 2 s, resulting in a measurement time of 20.5 h.
Bruker TopSpin versions 3.5pl6 and 3.2 were used to process NMR data. Topspin and Sparky (T. D.
Goddard and D. G. Kneller, SPARKY 3; University of California, San Francisco) were used to analyze and
assign NMR data.
Accession number(s). Accession numbers KY798410 and KY807157 (see Table 2) have been sub-
mitted to GenBank. All other accession numbers cited in the manuscript are already accessible.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.00641-18.
FIG S1, PDF ﬁle, 0.3 MB.
FIG S2, PDF ﬁle, 0.2 MB.
FIG S3, PDF ﬁle, 0.2 MB.
FIG S4, PDF ﬁle, 0.04 MB.
FIG S5, PDF ﬁle, 1.8 MB.
FIG S6, PDF ﬁle, 0.1 MB.
FIG S7, PDF ﬁle, 0.1 MB.
FIG S8, PDF ﬁle, 0.3 MB.
FIG S9, PDF ﬁle, 0.4 MB.
FIG S10, PDF ﬁle, 0.7 MB.
ACKNOWLEDGMENTS
We thank Heike Claus and Falk Büttner for providing genomic DNA of H. inﬂuenzae
serotype c and A. pleuropneumoniae serotype 7, respectively, and Jana Führing for
critically reading the manuscript.
This study received ﬁnancial support from MHH internal impact orientated funds
(LOM) to the Institute of Clinical Biochemistry, and a HiLF (Hochschulinterne Leistungs-
förderung) starter grant awarded to T.F.
TagF-Like Capsule Polymerases ®
May/June 2018 Volume 9 Issue 3 e00641-18 mbio.asm.org 19
 
m
bio.asm
.org
 o
n
 June 29, 2018 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
D.O. and F.B. are full-time employees of GSK vaccines. C.L., M.B., R.G.-S., and T.F. have
submitted patent applications in the presented ﬁeld of research. C.L. and T.F. designed
the study. T.F. identiﬁed the polymerase family and performed modelling. C.L. and T.F.
designed the experiments and analyzed data. C.L. and M.B. performed enzymatic
assays. I.B. performed analytical size exclusion chromatography (SEC). C.L., D.O., F.B.,
M.S., and T.F. recorded and analyzed NMR data. J.M. provided A. pleuropneumoniae
lysates and helpful discussions. R.G.-S. guided the design of the study and the inter-
pretation of results. C.L., M.S., and T.F. wrote the paper. All of us discussed the results
and gave feedback on the manuscript.
REFERENCES
1. Willis LM, Whitﬁeld C. 2013. Structure, biosynthesis, and function of
bacterial capsular polysaccharides synthesized by ABC transporter-
dependent pathways. Carbohydr Res 378:35–44. https://doi.org/10
.1016/j.carres.2013.05.007.
2. Roberts IS. 1996. The biochemistry and genetics of capsular polysaccha-
ride production in bacteria. Annu Rev Microbiol 50:285–315. https://doi
.org/10.1146/annurev.micro.50.1.285.
3. Geno KA, Gilbert GL, Song JY, Skovsted IC, Klugman KP, Jones C, Kon-
radsen HB, Nahm MH. 2015. Pneumococcal capsules and their types:
past, present, and future. Clin Microbiol Rev 28:871–899. https://doi.org/
10.1128/CMR.00024-15.
4. Whitﬁeld C. 2006. Biosynthesis and assembly of capsular polysaccharides
in Escherichia coli. Annu Rev Biochem 75:39–68. https://doi.org/10
.1146/annurev.biochem.75.103004.142545.
5. Harrison OB, Claus H, Jiang Y, Bennett JS, Bratcher HB, Jolley KA, Corton
C, Care R, Poolman JT, Zollinger WD, Frasch CE, Stephens DS, Feavers I,
Frosch M, Parkhill J, Vogel U, Quail MA, Bentley SD, Maiden MCJ. 2013.
Description and nomenclature of Neisseria meningitidis capsule locus.
Emerg Infect Dis 19:566–573. https://doi.org/10.3201/eid1904.111799.
6. Jessing SG, Ahrens P, Inzana TJ, Angen Ø. 2008. The genetic organisation
of the capsule biosynthesis region of Actinobacillus pleuropneumoniae
serotypes 1, 6, 7, and 12. Vet Microbiol 129:350–359. https://doi.org/10
.1016/j.vetmic.2007.12.003.
7. Kroll JS, Zamze S, Loynds B, Moxon ER. 1989. Common organization of
chromosomal loci for production of different capsular polysaccharides in
Haemophilus inﬂuenzae. J Bacteriol 171:3343–3347. https://doi.org/10
.1128/jb.171.6.3343-3347.1989.
8. Lo RYC, McKerral LJ, Hills TL, Kostrzynska M. 2001. Analysis of the capsule
biosynthetic locus of Mannheimia (Pasteurella) haemolytica A1 and
proposal of a nomenclature system. Infect Immun 69:4458–4464.
https://doi.org/10.1128/IAI.69.7.4458-4464.2001.
9. Lâm TT, Claus H, Frosch M, Vogel U. 2011. Sequence analysis of serotype-
speciﬁc synthesis regions II of Haemophilus inﬂuenzae serotypes c and
d: evidence for common ancestry of capsule synthesis in Pasteurellaceae
and Neisseria meningitidis. Res Microbiol 162:483–487. https://doi.org/
10.1016/j.resmic.2011.04.002.
10. Xu Z, Chen X, Li L, Li T, Wang S, Chen H, Zhou R. 2010. Comparative
genomic characterization of Actinobacillus pleuropneumoniae. J Bacte-
riol 192:5625–5636. https://doi.org/10.1128/JB.00535-10.
11. Lairson LL, Henrissat B, Davies GJ, Withers SG. 2008. Glycosyltransferases:
structures, functions, and mechanisms. Annu Rev Biochem 77:521–555.
https://doi.org/10.1146/annurev.biochem.76.061005.092322.
12. Breton C, Snajdrová L, Jeanneau C, Koca J, Imberty A. 2006. Structures
and mechanisms of glycosyltransferases. Glycobiology 16:29R–37R.
https://doi.org/10.1093/glycob/cwj016.
13. Freiberger F, Claus H, Günzel A, Oltmann-Norden I, Vionnet J, Mühlenhoff M,
Vogel U, Vann WF, Gerardy-Schahn R, Stummeyer K. 2007. Biochemical
characterization of a Neisseria meningitidis polysialyltransferase reveals
novel functional motifs in bacterial sialyltransferases. Mol Microbiol 65:
1258–1275. https://doi.org/10.1111/j.1365-2958.2007.05862.x.
14. Peterson DC, Arakere G, Vionnet J, McCarthy PC, Vann WF. 2011. Char-
acterization and acceptor preference of a soluble meningococcal group
C polysialyltransferase. J Bacteriol 193:1576–1582. https://doi.org/10
.1128/JB.00924-10.
15. McGowen MM, Vionnet J, Vann WF. 2001. Elongation of alternating alpha
2,8/2,9 polysialic acid by the Escherichia coli K92 polysialyltransferase. Gly-
cobiology 11:613–620. https://doi.org/10.1093/glycob/11.8.613.
16. Lizak C, Worrall LJ, Baumann L, Pﬂeiderer MM, Volkers G, Sun T, Sim L,
Wakarchuk W, Withers SG, Strynadka NCJ. 2017. X-ray crystallographic
structure of a bacterial polysialyltransferase provides insight into the
biosynthesis of capsular polysialic acid. Sci Rep 7:5842. https://doi.org/
10.1038/s41598-017-05627-z.
17. Sugiura N, Baba Y, Kawaguchi Y, Iwatani T, Suzuki K, Kusakabe T,
Yamagishi K, Kimata K, Kakuta Y, Watanabe H. 2010. Glucuronyltrans-
ferase activity of KﬁC from Escherichia coli strain K5 requires association
of KﬁA: KﬁC and KﬁA are essential enzymes for production of K5 poly-
saccharide, N-acetylheparosan. J Biol Chem 285:1597–1606. https://doi
.org/10.1074/jbc.M109.023002.
18. Romanow A, Haselhorst T, Stummeyer K, Claus H, Bethe A, Mühlenhoff
M, Vogel U, von Itzstein M, Gerardy-Schahn R. 2013. Biochemical and
biophysical characterization of the sialyl-/hexosyltransferase synthesiz-
ing the meningococcal serogroup W135 heteropolysaccharide capsule. J
Biol Chem 288:11718–11730. https://doi.org/10.1074/jbc.M113.452276.
19. Romanow A, Keys TG, Stummeyer K, Freiberger F, Henrissat B, Gerardy-
Schahn R. 2014. Dissection of hexosyl- and sialyltransferase domains in
the bifunctional capsule polymerases from Neisseria meningitidis W and
Y deﬁnes a new sialyltransferase family. J Biol Chem 289:33945–33957.
https://doi.org/10.1074/jbc.M114.597773.
20. Jing W, DeAngelis PL. 2003. Analysis of the two active sites of the hyaluro-
nan synthase and the chondroitin synthase of Pasteurella multocida. Gly-
cobiology 13:661–671. https://doi.org/10.1093/glycob/cwg085.
21. Jing W, Deangelis PL. 2000. Dissection of the two transferase activities of
the Pasteurella multocida hyaluronan synthase: two active sites exist in
one polypeptide. Glycobiology 10:883–889. https://doi.org/10.1093/
glycob/10.9.883.
22. Fiebig T, Berti F, Freiberger F, Pinto V, Claus H, Romano MR, Proietti D,
Brogioni B, Stummeyer K, Berger M, Vogel U, Costantino P, Gerardy-
Schahn R. 2014. Functional expression of the capsule polymerase of
Neisseria meningitidis serogroup X: a new perspective for vaccine de-
velopment. Glycobiology 24:150–158. https://doi.org/10.1093/glycob/
cwt102.
23. Fiebig T, Freiberger F, Pinto V, Romano MR, Black A, Litschko C, Bethe A,
Yashunsky D, Adamo R, Nikolaev A, Berti F, Gerardy-Schahn R. 2014.
Molecular cloning and functional characterization of components of the
capsule biosynthesis complex of Neisseria meningitidis serogroup A:
toward in vitro vaccine production. J Biol Chem 289:19395–19407.
https://doi.org/10.1074/jbc.M114.575142.
24. Muindi KM, McCarthy PC, Wang T, Vionnet J, Battistel M, Jankowska E,
Vann WF. 2014. Characterization of the meningococcal serogroup X
capsule N-acetylglucosamine-1-phosphotransferase. Glycobiology 24:
139–149. https://doi.org/10.1093/glycob/cwt091.
25. Fiebig T, Litschko C, Freiberger F, Bethe A, Berger M, Gerardy-Schahn R.
2018. Efﬁcient solid-phase synthesis of meningococcal capsular oligosac-
charides enables simple and fast chemoenzymatic vaccine production. J
Biol Chem 293:953–962. https://doi.org/10.1074/jbc.RA117.000488.
26. Ming SA, Cottman-Thomas E, Black NC, Chen Y, Veeramachineni V,
Peterson DC, Chen X, Tedaldi LM, Wagner GK, Cai C, Linhardt RJ, Vann
WF. 2018. Interaction of Neisseria meningit idis group X
N-acetylglucosamine-1-phosphotransferase with its donor substrate.
Glycobiology 28:100–107. https://doi.org/10.1093/glycob/cwx100.
27. Oldrini D, Fiebig T, Romano MR, Proietti D, Berger M, Tontini M, De Ricco
R, Santini L, Morelli L, Lay L, Gerardy-Schahn R, Berti F, Adamo R. 2018.
Combined chemical synthesis and tailored enzymatic elongation pro-
vide fully synthetic and conjugation-ready Neisseria meningitidis sero-
group X vaccine antigens. ACS Chem Biol 13:984–994. https://doi.org/
10.1021/acschembio.7b01057.
Litschko et al. ®
May/June 2018 Volume 9 Issue 3 e00641-18 mbio.asm.org 20
 
m
bio.asm
.org
 o
n
 June 29, 2018 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
28. Sperisen P, Schmid CD, Bucher P, Zilian O. 2005. Stealth proteins: in silico
identiﬁcation of a novel protein family rendering bacterial pathogens
invisible to host immune defense. PLoS Comput Biol 1:e63. https://doi
.org/10.1371/journal.pcbi.0010063.
29. Litschko C, Romano MR, Pinto V, Claus H, Vogel U, Berti F, Gerardy-
Schahn R, Fiebig T. 2015. The capsule polymerase CslB of Neisseria
meningitidis serogroup L catalyzes the synthesis of a complex trimeric
repeating unit comprising glycosidic and phosphodiester linkages. J Biol
Chem 290:24355–24366. https://doi.org/10.1074/jbc.M115.678094.
30. DeAngelis PL. 2012. Glycosaminoglycan polysaccharide biosynthesis and
production: today and tomorrow. Appl Microbiol Biotechnol 94:
295–305. https://doi.org/10.1007/s00253-011-3801-6.
31. Gagneux P, Varki A. 1999. Evolutionary considerations in relating oligo-
saccharide diversity to biological function. Glycobiology 9:747–755.
https://doi.org/10.1093/glycob/9.8.747.
32. Boratyn GM, Camacho C, Cooper PS, Coulouris G, Fong A, Ma N, Madden
TL, Matten WT, McGinnis SD, Merezhuk Y, Raytselis Y, Sayers EW, Tao T,
Ye J, Zaretskaya I. 2013. BLAST: a more efﬁcient report with usability
improvements. Nucleic Acids Res 41:W29–W33. https://doi.org/10.1093/
nar/gkt282.
33. Beynon LM, Richards JC, Perry MB. 1991. Structural studies of the cap-
sular polysaccharide from Actinobacillus pleuropneumoniae serotype
12. Carbohydr Res 212:219–227.
34. Branefors-Helander P, Classon B, Kenne L, Lindberg B. 1979. Structural
studies of the capsular antigen of Haemophilus inﬂuenzae type c. Car-
bohydr Res 76:197–202. https://doi.org/10.1016/0008-6215(79)80018-X.
35. Altman E, Brisson JR, Perry MB. 1986. Structural studies of the capsular
polysaccharide from Haemophilus pleuropneumoniae serotype 1.
Biochem Cell Biol 64:707–716. https://doi.org/10.1139/o86-097.
36. Altman E, Brisson J-R, Perry MB. 1988. Structural studies of the capsular
polysaccharide from Actinobacillus (Haemophilus) pleuropneumoniae se-
rotype 4. Biochem Cell Biol 66:998–1004. https://doi.org/10.1139/o88
-114.
37. Branefors-Helander P, Kenne L, Lindqvist B. 1980. Structural studies of
the capsular antigen from Haemophilus inﬂuenzae type f. Carbohydr Res
79:308–312. https://doi.org/10.1016/S0008-6215(00)83845-8.
38. Egan W, Tsui FP, Schneerson R. 1980. Structural studies of the Haemo-
philus inﬂuenzae type f capsular polysaccharide. Carbohydr Res 79:
271–277. https://doi.org/10.1016/S0008-6215(00)83839-2.
39. Brown S, Santa Maria JP, Walker S. 2013. Wall teichoic acids of Gram-
positive bacteria. Annu Rev Microbiol 67:313–336. https://doi.org/10
.1146/annurev-micro-092412-155620.
40. van der Es D, Hogendorf WFJ, Overkleeft HS, van der Marel GA, Codée
JDC. 2017. Teichoic acids: synthesis and applications. Chem Soc Rev
46:1464–1482. https://doi.org/10.1039/c6cs00270f.
41. Michon F, Roy R, Jennings HJ, Ashton FE. 1984. Structural elucidation of
the capsular polysaccharide of Neisseria meningitidis group H. Can J
Chem 62:1519–1524.
42. Jennings HJ, Rosell K-G, Kenny CP. 1979. Structural elucidation of the
capsular polysaccharide antigen of Neisseria meningitidis serogroup Z
using 13 C nuclear magnetic resonance. Can J Chem 57:2902–2907.
https://doi.org/10.1139/v79-474.
43. Fischer W, Schmidt MA, Jann B, Jann K. 1982. Structure of the Escherichia
coli K2 capsular antigen. Stereochemical conﬁguration of the glycerophos-
phate and distribution of galactopyranosyl and galactofuranosyl residues.
Biochemistry 21:1279–1284. https://doi.org/10.1021/bi00535a027.
44. Altman E, Brisson JR, Perry MB. 1987. Structural studies of the capsular
polysaccharide from Haemophilus pleuropneumoniae serotype 2.
Biochem Cell Biol 65:414–422. https://doi.org/10.1139/o87-053.
45. Altman E, Brisson JR, Perry MB. 1987. Structure of the capsular polysac-
charide of Haemophilus pleuropneumoniae serotype 3. Biochem Cell
Biol 65:960–967. https://doi.org/10.1139/o87-125.
46. Beynon LM, Perry MB, Richards JC. 1991. Structure of the capsular
polysaccharide from Actinobacillus pleuropneumoniae serotype 7. Car-
bohydr Res 209:211–223. https://doi.org/10.1016/0008-6215(91)80158-J.
47. Beynon LM, Richards JC, Perry MB. 1992. Nuclear-magnetic-resonance
analysis of the capsular antigen of Actinobacillus pleuropneumoniae
serotype 9. Its identity with the capsular antigen of Escherichia coli
K62 (K2ab), Neisseria meningitidis serogroup H and Pasteurella haemo-
lytica serotype T15. Eur J Biochem 210:119–124. https://doi.org/10.1111/
j.1432-1033.1992.tb17398.x.
48. Perry MB, Altman E, Brisson JR, Beynon LM, Richards JC. 1990. Structural
characteristics of the antigenic capsular polysaccharides and lipopoly-
saccharides involved in the serological classiﬁcation of Actinobacillus
(Haemophilus) pleuropneumoniae strains. Serodiagn Immunother Infect
Dis 4:299–300.
49. Blackall PJ, Bojesen AM, Christensen H, Bisgaard M. 2007. Reclassiﬁ-
cation of [Pasteurella] trehalosi as Bibersteinia trehalosi gen. nov.,
comb. nov. Int J Syst Evol Microbiol 57:666–674. https://doi.org/10
.1099/ijs.0.64521-0.
50. Richards JC, Leitch RA. 1990. Determination of the structure and
absolute conﬁguration of the glycerolphosphate-containing capsular
polysaccharide of Pasteurella haemolytica serotype T 3 by high-
resolution nuclear magnetic resonance spectroscopy. Can J Chem
68:1574–1584.
51. Adlam C, Knights JM, Mugridge A, Lindon JC, Williams JM. 1985.
Puriﬁcation, characterization and immunological properties of the
serotype-speciﬁc capsular polysaccharide of Pasteurella haemolytica
(serotype T4) organisms. J Gen Microbiol 131:387–394. https://doi
.org/10.1099/00221287-131-2-387.
52. Adlam C, Knights JM, Mugridge A, Lindon JC, Williams JM, Beesley JE.
1985. Puriﬁcation, characterization and immunological properties of the
capsular polysaccharide of Pasteurella haemolytica serotype T15: its
identity with the K62 (K2ab) capsular polysaccharide of Escherichia coli
and the capsular polysaccharide of Neisseria meningitidis serogroup H.
J Gen Microbiol 131:1963–1972. https://doi.org/10.1099/00221287-131
-8-1963.
53. Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJE. 2015. The
Phyre2 web portal for protein modeling, prediction and analysis. Nat
Protoc 10:845–858. https://doi.org/10.1038/nprot.2015.053.
54. Lovering AL, Lin LY, Sewell EW, Spreter T, Brown ED, Strynadka NCJ.
2010. Structure of the bacterial teichoic acid polymerase TagF provides
insights into membrane association and catalysis. Nat Struct Mol Biol
17:582–589. https://doi.org/10.1038/nsmb.1819.
55. Schertzer JW, Bhavsar AP, Brown ED. 2005. Two conserved histidine
residues are critical to the function of the TagF-like family of enzymes.
J Biol Chem 280:36683–36690. https://doi.org/10.1074/jbc.M507153200.
56. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R,
McWilliam H, Remmert M, Söding J, Thompson JD, Higgins DG. 2011.
Fast, scalable generation of high-quality protein multiple sequence
alignments using Clustal Omega. Mol Syst Biol 7:539. https://doi.org/10
.1038/msb.2011.75.
57. Osawa T, Sugiura N, Shimada H, Hirooka R, Tsuji A, Shirakawa T, Fukuy-
ama K, Kimura M, Kimata K, Kakuta Y. 2009. Crystal structure of chon-
droitin polymerase from Escherichia coli K4. Biochem Biophys Res Com-
mun 378:10–14. https://doi.org/10.1016/j.bbrc.2008.08.121.
58. Sobhanifar S, Worrall LJ, Gruninger RJ, Wasney GA, Blaukopf M, Baumann
L, Lameignere E, Solomonson M, Brown ED, Withers SG, Strynadka NCJ.
2015. Structure and mechanism of Staphylococcus aureus TarM, the wall
teichoic acid -glycosyltransferase. Proc Natl Acad Sci U S A 112:
E576–E585. https://doi.org/10.1073/pnas.1418084112.
59. D’Andrea LD, Regan L. 2003. TPR proteins: the versatile helix. Trends
Biochem Sci 28:655–662. https://doi.org/10.1016/j.tibs.2003.10.007.
60. Pace D. 2013. Glycoconjugate vaccines. Expert Opin Biol Ther 13:11–33.
https://doi.org/10.1517/14712598.2012.725718.
61. Costantino P, Rappuoli R, Berti F. 2011. The design of semi-synthetic and
synthetic glycoconjugate vaccines. Expert Opin Drug Discov
6:1045–1066. https://doi.org/10.1517/17460441.2011.609554.
62. Byrd W, Harmon BG, Kadis S. 1992. Protective efﬁcacy of conjugate
vaccines against experimental challenge with porcine Actinobacillus
pleuropneumoniae. Vet Immunol Immunopathol 34:307–324. https://
doi.org/10.1016/0165-2427(92)90172-M.
63. Byrd W, Kadis S. 1992. Preparation, characterization, and immunogenic-
ity of conjugate vaccines directed against Actinobacillus pleuropneu-
moniae virulence determinants. Infect Immun 60:3042–3051.
64. Adamo R. 2017. Advancing homogeneous antimicrobial glycoconju-
gate vaccines. Acc Chem Res 50:1270–1279. https://doi.org/10.1021/
acs.accounts.7b00106.
65. LaForce FM, Konde K, Viviani S, Préziosi MP. 2007. The meningitis vaccine
project. Vaccine 25(Suppl 1):A97–A100. https://doi.org/10.1016/j.vaccine
.2007.04.049.
66. Xie O, Pollard AJ, Mueller JE, Norheim G. 2013. Emergence of serogroup
X meningococcal disease in Africa: need for a vaccine. Vaccine 31:
2852–2861. https://doi.org/10.1016/j.vaccine.2013.04.036.
67. Fiebig T, Romano MR, Oldrini D, Adamo R, Tontini M, Brogioni B, Santini
L, Berger M, Costantino P, Berti F, Gerardy-Schahn R. 2016. An efﬁcient
TagF-Like Capsule Polymerases ®
May/June 2018 Volume 9 Issue 3 e00641-18 mbio.asm.org 21
 
m
bio.asm
.org
 o
n
 June 29, 2018 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
cell free enzyme-based total synthesis of a meningococcal vaccine
candidate. NPJ Vaccines 1:16017. https://doi.org/10.1038/npjvaccines
.2016.17.
68. Kugadas A, Humann JL, Pierlé SA, Srikumaran S, Brayton KA. 2016.
Genome sequence of Bibersteinia trehalosi strain Y31 isolated from the
pneumonic lung of a bighorn sheep. Genome Announc 4:e00722-16.
https://doi.org/10.1128/genomeA.00722-16.
69. Harhay GP, McVey DS, Koren S, Phillippy AM, Bono J, Harhay DM,
Clawson ML, Heaton MP, Chitko-McKown CG, Korlach J, Smith TPL. 2014.
Complete closed genome sequences of three Bibersteinia trehalosi na-
sopharyngeal isolates from cattle with shipping fever. Genome Announc
2:e00084-14. https://doi.org/10.1128/genomeA.00084-14.
70. Min H, Cowman MK. 1986. Combined alcian blue and silver staining of
glycosaminoglycans in polyacrylamide gels: application to electrophoretic
analysis of molecular weight distribution. Anal Biochem 155:275–285.
https://doi.org/10.1016/0003-2697(86)90437-9.
Litschko et al. ®
May/June 2018 Volume 9 Issue 3 e00641-18 mbio.asm.org 22
 
m
bio.asm
.org
 o
n
 June 29, 2018 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
